These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8429536)

  • 21. Phenotypic and molecular characterization of 5 novel CTX-M enzymes carried by Klebsiella pneumoniae and Escherichia coli.
    Cheng J; Ye Y; Wang YY; Li H; Li X; Li JB
    Acta Pharmacol Sin; 2008 Feb; 29(2):217-25. PubMed ID: 18215351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo selection of a complex mutant TEM (CMT) from an inhibitor-resistant TEM (IRT) during ceftazidime therapy.
    Jacquier H; Marcadé G; Raffoux E; Dombret H; Woerther PL; Donay JL; Arlet G; Cambau E
    J Antimicrob Chemother; 2013 Dec; 68(12):2792-6. PubMed ID: 23861309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The kinetics of CAZ-5, a novel SHV-related plasmid-mediated beta-lactamase with enhanced hydrolytic activity against ceftazidime.
    Labia R; Thabaut A; Morand A; Tiwari K; Sirot D; Sirot J
    Drugs Exp Clin Res; 1989; 15(11-12):535-40. PubMed ID: 2700319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of beta-lactamase stability and antibacterial activity of beta-lactams in beta-lactamase-producing bacteria and respective transconjugants.
    Esposito S; Galante D; Barba D; Pennucci C; Limauro D
    Drugs Exp Clin Res; 1986; 12(4):329-33. PubMed ID: 3522155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative in vitro activity and beta-lactamase stability of CGP 31523A, a new aminothiazolyl cephalosporin.
    Chin NX; Neu HC
    Chemioterapia; 1986 Apr; 5(2):92-100. PubMed ID: 3518967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Semi-quantification of a microbiological method using beta-lactamases in detecting the hydrolysis of beta-lactam antibiotics.
    Labia R; Guionie M
    Ann Microbiol (Paris); 1981; 132B(2):257-65. PubMed ID: 7034613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cefotaxime and ceftazidime-resistant Escherichia coli isolate producing TEM-15 beta-lactamase from a Tunisian hospital.
    Chouchani C; Ben-Achour N; M'charek A; Belhadj O
    C R Biol; 2007 Aug; 330(8):565-70. PubMed ID: 17637436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.
    Jones RN; Barry AL
    Eur J Clin Microbiol; 1987 Oct; 6(5):570-1. PubMed ID: 3501757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. beta-Lactamase stability and in vitro activity of oral cephalosporins against strains possessing well-characterized mechanisms of resistance.
    Sanders CC
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1313-7. PubMed ID: 2802558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel SHV-derived extended-spectrum beta-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin.
    Ma L; Alba J; Chang FY; Ishiguro M; Yamaguchi K; Siu LK; Ishii Y
    Antimicrob Agents Chemother; 2005 Feb; 49(2):600-5. PubMed ID: 15673739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Types of beta-lactamase determined by plasmids in gram-negative bacteria.
    Matthew M; Hedges RW; Smith JT
    J Bacteriol; 1979 Jun; 138(3):657-62. PubMed ID: 378931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical characteristics of extended broad spectrum beta-lactamases.
    Bush K; Singer SB
    Infection; 1989; 17(6):429-33. PubMed ID: 2613337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel plasmid-mediated extended-spectrum beta-lactamase not derived from TEM- or SHV-type enzymes.
    Bernard H; Tancrede C; Livrelli V; Morand A; Barthelemy M; Labia R
    J Antimicrob Chemother; 1992 May; 29(5):590-2. PubMed ID: 1624397
    [No Abstract]   [Full Text] [Related]  

  • 34. A survey of the kinetic parameters of class C beta-lactamases. Cephalosporins and other beta-lactam compounds.
    Galleni M; Amicosante G; Frère JM
    Biochem J; 1988 Oct; 255(1):123-9. PubMed ID: 3264155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceftibuten stability to active-site serine and metallo-beta-lactamases.
    Perilli M; Segatore B; Franceschini N; Gizzi G; Mancinelli A; Caravelli B; Setacci D; del Tavio-Perez MM; Bianchi B; Amicosante G
    Int J Antimicrob Agents; 2001 Jan; 17(1):45-50. PubMed ID: 11137648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. beta-Lactamase hydrolysis of cephalosporin 3'-quinolone esters, carbamates, and tertiary amines.
    Georgopapadakou NH; McCaffrey C
    Antimicrob Agents Chemother; 1994 May; 38(5):959-62. PubMed ID: 8067776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological properties of beta-lactamases that hydrolyze cefuroxime and cefotaxime.
    Hirai K; Sato K; Matsubara N; Katsumata R; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1981 Aug; 20(2):262-4. PubMed ID: 6269489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An engineered Staphylococcus aureus PC1 beta-lactamase that hydrolyses third-generation cephalosporins.
    Zawadzke LE; Smith TJ; Herzberg O
    Protein Eng; 1995 Dec; 8(12):1275-85. PubMed ID: 8869640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural and mechanistic insights into NDM-1 catalyzed hydrolysis of cephalosporins.
    Feng H; Ding J; Zhu D; Liu X; Xu X; Zhang Y; Zang S; Wang DC; Liu W
    J Am Chem Soc; 2014 Oct; 136(42):14694-7. PubMed ID: 25268575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Affinity of cefmenoxime for beta-lactamases: an analysis.
    Labia R; Morand A; Verchere-Beaur C; Bryskier A
    Am J Med; 1984 Dec; 77(6A):25-7. PubMed ID: 6097119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.